Medifron DBT Co. Ltd (065650) — Capital Reinvestment Ratio
Medifron DBT Co. Ltd (065650) has a Capital Reinvestment Ratio of 0.00x as of June 2025, meaning it reinvests 0% of its operating cash flow (₩6.72 Billion) in capital expenditures (₩22.85 Million). See Medifron DBT Co. Ltd (065650) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Medifron DBT Co. Ltd Capital Reinvestment Ratio (2011–2014)
This chart tracks Medifron DBT Co. Ltd's Capital Reinvestment Ratio across 2 annual periods. Check cash flow reinvestment rate of Medifron DBT Co. Ltd to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Medifron DBT Co. Ltd (2011–2014)
Year-by-year Capital Reinvestment Ratio for Medifron DBT Co. Ltd from 2011 to 2014. For live market cap and broader valuation context, see Medifron DBT Co. Ltd (065650) total market value.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2014 | 38.34x | ₩701.96K | ₩26.91 Million | ▲ +129467.7% |
| 2011 | 0.03x | ₩912.56 Million | ₩27.00 Million | — |